Home 5 Clinical Diagnostics Insider 5 G2 Insider: Zinc Protoporphyrin May Be Effective Screen for Iron Deficiency in Infants

G2 Insider: Zinc Protoporphyrin May Be Effective Screen for Iron Deficiency in Infants

by | Feb 21, 2015 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, G2 Insider-dtet

Zinc protoporphyrin (ZPP) may be a simple screening test for iron deficiency (ID) and iron deficiency anemia in infants and toddlers, according to a study published online Feb. 18 in JAMA Pediatrics. Despite recommendations for universal screening for ID in all 1-year-olds, diagnosis remains a challenge for primary care clinicians because of the lack of an ideal screening test. The authors say that using hemoglobin as a first screen misses large groups of infants with ID without anemia. The 2010 American Academy of Pediatrics recommendations call for screening for ID with ferritin and C-reactive protein or serum transferrin receptor-1 saturation and reticulocyte hemoglobin level, which are not routinely available to practitioners. “The [ZPP] test is cheap and can be done on capillary blood at the point of service,” writes Robert Baker, M.D., Ph.D., from Children’s Hospital of Buffalo in N.Y., in an accompanying editorial. “However, there are a number of factors that affect ZPP levels including lead poisoning, myelodysplasia, chronic inflammation, and altered iron metabolism.” The JAMA Pediatrics study retrospectively reviewed longitudinal electronic medical records data collected at a primary care center (2002 to 2010) among 2,612 kids (between the ages of 8 months and 18 months) seen for routine […]

Subscribe to Clinical Diagnostics Insider to view

Start a Free Trial for immediate access to this article